Jennison Associates’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.1M | Sell |
1,987,118
-132,649
| -6% | -$3.81M | 0.03% | 201 |
|
|
2025
Q1 | $71.1M | Sell |
2,119,767
-588,584
| -22% | -$19.7M | 0.05% | 161 |
|
|
2024
Q4 | $138M | Sell |
2,708,351
-85,263
| -3% | -$4.36M | 0.08% | 106 |
|
|
2024
Q3 | $143M | Buy |
2,793,614
+13,470
| +0.5% | +$688K | 0.09% | 94 |
|
|
2024
Q2 | $125M | Sell |
2,780,144
-37,710
| -1% | -$1.69M | 0.08% | 98 |
|
|
2024
Q1 | $132M | Buy |
2,817,854
+270,171
| +11% | +$12.6M | 0.09% | 94 |
|
|
2023
Q4 | $90.6M | Buy |
2,547,683
+1,113,992
| +78% | +$39.6M | 0.07% | 124 |
|
|
2023
Q3 | $42.6M | Buy |
1,433,691
+972,194
| +211% | +$28.9M | 0.04% | 196 |
|
|
2023
Q2 | $8.32M | Buy |
+461,497
| New | +$8.32M | 0.01% | 391 |
|